TITLE

Understanding the polio vaccine

AUTHOR(S)
Montgomery, Anne
PUB. DATE
June 1996
SOURCE
Mothering;Summer96, Issue 79, p38
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Discusses information about polio and the polio vaccine. Background on polymyelitis; Symptoms of polio; Vaccines used against polio; Types of vaccinations.
ACCESSION #
9604175695

 

Related Articles

  • Status of poliomyelitis eradication in the WHO European region.  // Bulletin of the World Health Organization;1995, Vol. 73 Issue 1, p123 

    Reports on the status of the poliomyelitis eradication initiative in the World Health Organization's (WHO) European region. Distribution of the disease as of 1993; Shortages of the oral poliovirus vaccine (OPV); Need for the addition of immunization strategies.

  • New polio vaccine: Back to the future? Levin, Arthur A. // HealthFacts;Aug96, Vol. 21 Issue 207, p2 

    Reports on the development of a new enhanced inactivated polio vaccine (IPV). Replacement of the Salk vaccine; US Centers for Disease Control and Prevention's recommendation of the vaccine for the first two doses of the childhood immunization schedule.

  • Will switch to injections stop vaccine-caused polio?  // Second Opinion;Nov96, Vol. 6 Issue 11, p6 

    Focuses on the issue of the replacement of the Sabin oral polio vaccine with a Salk-type injection. Number of polio cases per year that are caused by the Sabin vaccine; History of inducing of vaccine-caused polio by the Salk-type injection.

  • Any questions. Elliman, David // BMJ: British Medical Journal (International Edition);4/22/95, Vol. 310 Issue 6986, p1044 

    Reports on the estimated number of cases of poliomyelitis related to the live vaccine in England and Wales, between 1985 and 1991. Estimated risk of a recipient oral polio vaccine developing paralytic polio; Need for full immunization against poliomyelitis.

  • Certification of poliomyelitis eradication--the Americas, 1994.  // MMWR: Morbidity & Mortality Weekly Report;10/7/1994, Vol. 43 Issue 39, p720 

    Reports on the steps taken by the Pan American Health Organization (PAHO) to certify the eradication of polio in the Americas after a 5-year period. Interruption of wild poliovirus transmission; Continuance of wild poliovirus transmission outside the Americas compelling need to maintain high...

  • Progress toward poliomyelitis eradication--India, December 1995 and January 1996.  // MMWR: Morbidity & Mortality Weekly Report;5/10/1996, Vol. 45 Issue 18, p370 

    Reports on the progress toward polio eradication in India and indicates that the target to vaccinate 75 million children aged 3 years with oral poliovirus vaccine (OPV) was exceeded by 4.3 million during the first round of pulse polio immunization days (PPID) and by 10.4 million during the...

  • Eradication of Poliomyelitis. Sabin, Albert B. // Annals of Internal Medicine;Sep61, Vol. 55 Issue 3, p353 

    Discusses the acquired knowledge which justifies the expectation that poliomyelitis may be eradicated from large areas of the world. Primary site for multiplication of the polioviruses; Development of the killed-virus vaccine; Immunity produced by orally administered, live attenuated poliovirus...

  • A shot in the dark. Wechsler, Pat // New York;11/11/96, Vol. 29 Issue 44, p38 

    Reports that early batches of Jonas Salk's polio vaccine were contaminated by a virus named Simian Virus 40 (SV40). The virus originating in the renal cells of the rhesus and cynomolgus monkeys with which the vaccine was made; The millions of batches of the vaccine thought to have been...

  • The first two doses of polio vaccine.  // FDA Consumer;May/Jun97, Vol. 31 Issue 4, p38 

    Focuses on the recommendation of the national Centers for Disease Control (CDC) in United States about polio vaccine given to children. Information about the routes of the first two doses and the second two doses of polio vaccine; Reason why the CDC implemented this recommendation.

  • Which polio vaccine to use?  // Child Health Alert;Nov96, Vol. 14, p3 

    Compares the effectiveness of oral and parenteral polio vaccines. Levels of immunity produced by the two types of vaccine; Development of polio from the weakened but still live virus in the oral polio vaccine; US Centers for Disease Control and Prevention's changing of the recommendation for...

Share

Read the Article

Other Topics